Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Elections for Interim Dividend

1st Sep 2014 12:00

SHIRE PLC - Elections for Interim Dividend

SHIRE PLC - Elections for Interim Dividend

PR Newswire

London, September 1

Elections for Interim Dividend in Respect of the Six Months to June 30, 2014 September 1, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG) announced on July 18,2014 an interim dividend of 3.83 US cents per Ordinary Share payable on October3, 2014 to shareholders on the register of members at the close of business onSeptember 5, 2014. Shareholders are reminded that the final date for submission of elections toreceive UK sourced dividends via the income access share arrangements isSeptember 5, 2014. In the absence of any such elections, previous elections or deemed electionswill remain in force. Shareholders who do not elect (or have not been deemed to elect) to receive UKsourced dividends through the income access share arrangements are remindedthat their dividends will be Irish sourced and subject to Irish dividendwithholding tax unless the Company's Registrar is in possession of a validexemption form by 5pm on September 5, 2014. Exemption forms may be submittedby email to [email protected] Enquiries may be addressed to the Company's Registrar's Dividend Planning Teamon +44 (0) 1903 854 103. Tony GuthrieDeputy Company Secretary For further information please contact: Investor Relations Jeff Poulton [email protected] +1 781 482 0945 Sarah Elton-Farr [email protected] +44 1256 894157 Media Stephanie Fagan [email protected] +1 781 482 0460 Gwen Fisher [email protected] +1 484 595 9836 NOTES TO EDITORS Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialtymedicines to meet significant unmet patient needs. We focus on providing treatments in Neuroscience, Rare Diseases,Gastrointestinal, and Internal Medicine and we are developing treatments forsymptomatic conditions treated by specialist physicians in other targetedtherapeutic areas, such as Ophthalmology. www.shire.com Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Release www.shire.com

Related Shares:

Shire
FTSE 100 Latest
Value8,781.12
Change81.81